Retatrutide 10mg
136,90 €
View the certificate of analysis and HPLC purity verification for this batch.
Description
↺ 14-DAY MONEY-BACK
✈ SHIPS WITHIN 24H
Retatrutide 10 mg
Research-grade lyophilized peptide powder in a sterile glass vial. Retatrutide (LY3437943) is an investigational triple receptor agonist engaging GIP, GLP-1 and glucagon receptors in parallel — one of the most closely watched compounds in current metabolic research.
Retatrutide belongs to the newest generation of incretin-based research peptides: a single molecule designed to activate three metabolic receptor systems at once. In preclinical models it serves as a tool compound for dissecting how combined GIP, GLP-1 and glucagon receptor signaling shapes energy balance, glucose handling and adiposity — questions that single- and dual-agonist tools cannot fully answer.
Mechanistic work on receptor selectivity, signaling bias and downstream pathway crosstalk under simultaneous GIP, GLP-1 and glucagon receptor activation.
In vivo studies tracking food intake, adipose tissue dynamics and energy expenditure under multi-agonist signaling.
Research on glucose tolerance, insulin dynamics and hepatic glucose output in preclinical systems.
Benchmarking triple agonism against single and dual agonists to isolate the contribution of each receptor axis.
NOT FOR HUMAN OR VETERINARY USE · NOT A FOOD, SUPPLEMENT, COSMETIC OR MEDICINE · ALL CONTENT IS EDUCATIONAL ONLY

Reviews
There are no reviews yet.